Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 361–420 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

Dana Farber Cancer Institute5 ED5 Edinburgh University5 England5 GSK5 General Hospital5 Health Research Authority5 Health and Care Research Wales5 Heidelberg University Hospital5 Hospital Pharmacy Department5 Institute for Healthcare Improvement5 J Adv Nurs 20255 JAMA Psychiatry5 James Lind Alliance5 KU Leuven5 Leeds Teaching Hospitals5 Leiden University Medical Centre5 Level 1 trauma center5 MESH Registry5 NCT033015065 National Institute for Clinical Excellence5 Oncology5 Oslo University Hospital5 PAIS Index5 PsychINFO5 PubMed Central5 Radboud University Medical Center5 Royal College of Physicians5 Royal Free5 SNIS5 Simon Fraser University5 Sociological Abstracts5 South London and Maudsley NHS Foundation Trust5 St James’s Hospital5 Swedish CArdioPulmonary BioImage Study5 Synaptogenix5 Tikur Anbessa Specialized Hospital5 UN Digital Library5 University Medical Centre Ljubljana5 University of British Columbia5 University of Manitoba5 University of Melbourne5 University of Michigan5 World Health Organisation5 stroke centers5 Arm B4 ESMO4 Arm A4 Caris Life Sciences4 Stryker Neurovascular4 SIT4 ELSA4 HSS4 ESRA4 FDA-approved4 West China Hospital of Sichuan University4 Cass Review4 Cleveland Clinic4 European Kidney Function Consortium4 NHS Tayside4

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 147 of 946

PO:08:199 Safe, supported, informed: a survey of what people with SLE want to know about pregnancy

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

86.2%

Lupus UK University College London Hospital Systemic Lupus Erythematosus physical therapy SLE

…source was their doctor in 20/47 (40%), followed by the charity Lupus UK in 18/47 (38%), Google search engine in 18/47 (38%), other heal…

PO:09:248 Real-world data on voclosporin for the treatment of lupus nephritis including use of concomitant biologic therapies: an analysis of the Enlight-LN registry

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

89.9%

Enlight-LN registry NCT05337124 voclosporin obinutuzumab belimumab anifrolumab systemic lupus erythematosus mycophenolate mofetil rituximab Class V disease+2 more

…ne characteristics and demographics of patients enrolled in the Enlight-LN registry and detail the use of concomitant medications, specifically bio…

PO:11:283 Efficacy of anifrolumab in the treatment of cutaneous lupus erythematosus: a scoping review

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

77.9%

Cochrane Library Scopus PubMed Anifrolumab Discoid lupus erythematosus Lupus panniculitis tumid lupus chilblain lupus Rowell syndrome livedo reticularis+1 more

…wing PRISMA-ScR guidelines. PubMed, Scopus, Web of Science, and Cochrane Library were searched from inception to October 10, 2025, without langu…

PO:11:294 Five-year safety of belimumab in SLE: insights from the global, prospective, observational SABLE registry

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

89.5%

GSK Study 116543 SABLE registry NCT01729455 SLE Belimumab BEL

…hods The real-world, prospective, observational SABLE registry (GSK Study 116543; NCT01729455) enrolled patients with active SLE (2013–2020), tr…

PO:12:329 Retrospective analysis of cutaneous lupus erythematosus (CLE) manifestations seen in a tertiary lupus dermatology clinic

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

86.5%

Barts Health Lupus Centre Barts Health LupusUK Centre of Excellence Mile End Hospital Rituximab mycophenolate mofetil hydroxychloroquine systemic lupus erythematosus prednisolone methotrexate lupus profundus+5 more

… July 2024 and July 2025 in the Lupus-Dermatology Clinic at the Barts Health Lupus Centre (Mile End Hospital). Data collected included demographics (sex,…

PO:12:331 Tailored support and transportation: improving access to care for patients with lupus through transportation assistance and pharmacy education

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

93.4%

University of North Carolina UNC Systemic lupus erythematosus Pharmacist counseling transportation support Uber Health

…(EHR) data repository of patients who have been admitted to the University of North Carolina (UNC) healthcare system. Project personnel pre-screened patient…

PT6:05 Susceptibility to pneumocystis jirovecii pneumonia and predisposing disease-modifying antirheumatic drugs in systemic lupus erythematosus: a cohort study from the largest health care system in Taiwan

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

83.5%

CGRD Chang Gung Research Database systemic lupus erythematosus leflunomide cyclosporin azathioprine mycophenolate methotrexate Pneumocystis jirovecii pneumonia SLE

…diagnosed as either SLE or other RMDs during 2005-2020 from the CGRD. After propensity score matching, 3745 patients per group were …

PT7:01 When dialogue becomes innovation: LupusGPT as a model of doctor–patient co-creation in rheumatology

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

87.8%

Lupus Europe Ann Rheum Dis Autoimmun Rev systemic lupus erythematosus PFMD SLE Lupus

…alogue evolved into a shared idea. Building on that foundation, Lupus Europe coordinated a collaborative development process, engaging lupus…

S1:04 Enpatoran, a toll-like receptor 7/8 inhibitor, in skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: pooled safety data from the phase 2 willow trial

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

93.5%

WILLOW lupus Enpatoran SLE

…pants with cutaneous manifestations of lupus at baseline in the WILLOW study, consistent with the overall study population and other p…

Influence of lifestyle factors on susceptibility, disease course and recovery from post COVID-19 syndrome: a scoping review

bmjph · abstract · 2026-02-27 · 3 matching annotations

92.7%

PubMed Cochrane Library Scopus cognitive behavioural therapy

…ematic reviews, clinical studies and additional literature from PubMed (MEDLINE), Scopus and the Cochrane Library (January 2022 to Dec…

Delivering hospital care at home in a Dutch Tertiary University Hospital: protocol for a prospective feasibility cohort study evaluating a Virtual Ward for early discharge of inpatients

bmjopen · abstract · 2026-02-24 · 3 matching annotations

92.7%

Erasmus University Medical Center Erasmus MC severe inflammatory skin disease high-dose corticosteroid treatment decompensated heart failure viral respiratory infections dehydration

…single-centre prospective feasibility cohort study conducted at Erasmus University Medical Center (Erasmus MC), Rotterdam, the Netherlands. The study encompasses…

Exploring potential pathogenesis mechanisms of onchocerciasis-associated epilepsy through cerebrospinal fluid analysis of children with complex febrile seizures: a pilot study in Aketi, Democratic Republic of the Congo

bmjopen · abstract · 2026-02-24 · 3 matching annotations

94.5%

University of Antwerp University of Kisangani Pan African Clinical Trials Registry ivermectin Onchocerciasis onchocerciasis-endemic ivermectin-naïve onchocerciasis-associated epilepsy river blindness

…of the University of Kisangani (UNIKIS/CE/KGB/001/2025) and the University of Antwerp (project ID 7323-Edge n/a-BUN B3002025000078). Written informed…